Home Newsfeeds AMD Says Prudently Controlling Operating Expenses And Headcount Growth

News

AMD Says Prudently Controlling Operating Expenses And Headcount Growth

-Reuters

byBenzinga Newsdesk

November 1, 2022

1 minute read

-Reuters

News

374Water Set To Join Russell 3000 Index, Another Milestone Achievement For Sustainable Innovation

By Benzinga Newsdesk

June 23, 8:07 AM

374Water (NASDAQ:SCWO), a leader in sustainable technology and innovation, is pleased to announce it is set to join the broad-market Russell 3000® and Russell Microcap® Indexes at the conclusion of the 2023

SCWO

Tetra’s Diversified Future: Lithium, Zinc Bromide, And Water Recycling Poised To Reshape Earnings, Highlights Analyst

By Lekha Gupta

September 28, 3:16 PM

Benchmark analyst Kurt Hallead initiated coverage on Tetra Technologies Inc (NYSE: TTI) with a Buy rating

EOSE

FDA Approves scPharmaceuticals’ Self-Administered Med For Congestion in Chronic Heart Failure

By Vandana Singh

October 10, 9:24 AM

The FDA has approved scPharmaceuticals Inc’s (NASDAQ:SCPH) Furoscix (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for…

SCPH

‘Nasdaq Halts Plan For Crypto Custody Service Due To U.S. Regulatory Conditions’ – CoinDesk

By Happy Mohamed

July 19, 9:15 AM

https://www.coindesk.com/business/2023/07/19/nasdaq-halts-plan-for-crypto-custody-service-due-to-us-regulatory-conditions/?utm_source=twitter&utm_medium=social&utm_content=editorial&utm_term=organic&utm_c

BTC

AMD Says Prudently Controlling Operating Expenses And Headcount Growth

Related Posts

374Water Set To Join Russell 3000 Index, Another Milestone Achievement For Sustainable Innovation

Tetra’s Diversified Future: Lithium, Zinc Bromide, And Water Recycling Poised To Reshape Earnings, Highlights Analyst

FDA Approves scPharmaceuticals’ Self-Administered Med For Congestion in Chronic Heart Failure

‘Nasdaq Halts Plan For Crypto Custody Service Due To U.S. Regulatory Conditions’ – CoinDesk